HOT NEWS
Bayer
The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Bayer HealthCare joins forces with Stroke Alliance for Europe 828
2 Bayer HealthCare to broaden strategic alliance with German Cancer Research Center 1427
3 Bayer supports innovative drug discovery in Europe 2442
4 Bayer supports pharmaceutical research in Europe 4702
5 Bayer's Xarelto® (Rivaroxaban) approved for the treatment of pulmonary embolism (PE) and the prevention of recurrent deep vein thrombosis (DVT) and PE 4174
6 Latest Xarelto® (Rivaroxaban) data to be presented at ESC Congress 2012 4092
7 UK's NICE recommends Bayer's Xarelto® 4295
8 Bayer enters into strategic partnership with Covance 5050
9 Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Secondary Prevention after an Acute Coronary Syndrome 10407
10 Results of ROCKET AF Study of Bayer’s Xarelto® (Rivaroxaban) 7350
11 Bayer continues positive momentum 6949
12 Bayer advances research in the area of pulmonary hypertension 7562
13 VEGF Trap-Eye Submitted for EU Marketing Authorization 7949
14 Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes 7999
15 Bayer off to a successful start to 2011 6902
16 Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives 7080
17 Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 6783
18 OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics 7419
19 Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy 7310
20 Organizational changes at Bayer HealthCare 5176
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3